Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) PDPK1 Antibodies:
anti-Human PDPK1 Antibodies:
anti-Mouse (Murine) PDPK1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal PDPK1 Primary Antibody for IHC - ABIN966816
Scheid, Parsons, Woodgett: Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation. in Molecular and cellular biology 2005
Show all 5 Pubmed References
Human PDPK1 Primary Antibody for IHC - ABIN966815
Chen, Nystrom, Dong, Li, Song, Liu, Quon: Insulin stimulates increased catalytic activity of phosphoinositide-dependent kinase-1 by a phosphorylation-dependent mechanism. in Biochemistry 2001
Show all 4 Pubmed References
Human Monoclonal PDPK1 Primary Antibody for ICC, FACS - ABIN969347
Seong, Jung, Kim, Ha: 3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins. in The Journal of biological chemistry 2007
Show all 3 Pubmed References
Human Polyclonal PDPK1 Primary Antibody for WB - ABIN250778
Ho, Coomber: Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells. in Experimental cell research 2015
Show all 3 Pubmed References
Human Polyclonal PDPK1 Primary Antibody for ICC, IF - ABIN250776
Tsoi, Li, Chen, Lau, Tsui, Chan: The SARS-coronavirus membrane protein induces apoptosis via interfering with PDK1-PKB/Akt signalling. in The Biochemical journal 2014
Show all 3 Pubmed References
Human Polyclonal PDPK1 Primary Antibody for ELISA, WB - ABIN269845
Sarbassov, Guertin, Ali, Sabatini: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. in Science (New York, N.Y.) 2005
Show all 2 Pubmed References
Human Polyclonal PDPK1 Primary Antibody for IF, IHC - ABIN361882
Sato, Fujita, Tsuruo: Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3. in The Journal of biological chemistry 2002
Show all 6 Pubmed References
Human Polyclonal PDPK1 Primary Antibody for IHC, IHC (p) - ABIN4344572
Fack, Espedal, Keunen, Golebiewska, Obad, Harter, Mittelbronn, Bähr, Weyerbrock, Stuhr, Miletic, Sakariassen, Stieber, Rygh, Lund-Johansen, Zheng, Gottlieb, Niclou, Bjerkvig: Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. in Acta neuropathologica 2015
Human Polyclonal PDPK1 Primary Antibody for IF (p), IHC (p) - ABIN744668
Lin, Lin, Kang, Liu, Wang, Zheng, Yu, Lin: Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy. in Epilepsy research 2015
Human Polyclonal PDPK1 Primary Antibody for IF, IHC - ABIN362492
Lim, Kikani, Wick, Dong: Nuclear translocation of 3'-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function. in Proceedings of the National Academy of Sciences of the United States of America 2003
Show all 6 Pubmed References
miR (show MYLIP Antibodies)-375 directly targeted PDK1 (show PDK1 Antibodies) in porcine pancreatic stem cells suppressing cell proliferation and differentiation into islet-like cells.
Our experimental results suggested that PDK1 (show PDK1 Antibodies) may promote chondrocyte apoptosis in osteoarthritis via p38 MAPK (show MAPK14 Antibodies) signaling pathway
ATP5G1 (show ATP5G1 Antibodies), ATP5G2 (show ATP5G2 Antibodies), and ATP5G3 (show ATP5G3 Antibodies) of the ATP synthase are not involved in forming the permeability transition pore.
our results offer significant insight into how PIK3CA (show PIK3CA Antibodies) overexpression drives squamous cell carcinoma (HNSCC) invasion and metastasis, providing a rationale for targeting PI3K (show PIK3CA Antibodies)/PDK1 (show PDK1 Antibodies) and TGFb (show TGFB1 Antibodies) signaling in advanced HNSCC patients with PIK3CA (show PIK3CA Antibodies) amplification
Ribociclib, in combination with GSK2334470 or the PI3Kalpha (show PIK3CA Antibodies) inhibitor alpelisib, decreased xenograft tumor growth more potently than each drug alone. Taken together, our results highlight a role for the PI3K (show PIK3CA Antibodies)-PDK1 (show PDK1 Antibodies) signaling pathway in mediating acquired resistance to CDK4/6 (show CDK4 Antibodies) inhibitors.
Decreased PDK1 (show PDK1 Antibodies) protein expression in A2058 cells.
Together these results indicate a strong potential regulatory role for PDK1 (show PDK1 Antibodies) in OC stimulatory pathways (Akt (show AKT1 Antibodies), ERK (show EPHB2 Antibodies)) and autophagy induction (via mTORC1), which may contribute to the OC phenotype in Paget's disease of bone.
It targeted the 3-phosphoinositide-dependent protein kinase 1 gene that appeared to be a potent regulator of AKT (show AKT1 Antibodies).
High (show PDK1 Antibodies)ly expressed PDK1 could promote cell invasion and secretion of IL-1beta and IL-6 in human rheumatoid arthritis s (show PDK1 Antibodies)ynovial (show PDK1 Antibodies)MH7A c (show RPS6KA3 Antibodies)ells. Inhib (show RPS6KA3 Antibodies)ition of RSK2 reduced the PDK (show ASF1A Antibodies)1-induced cell invasion and cytokines secretion (show PDK1 Antibodies) in M (show RPS6KA3 Antibodies)H7A cells. In response to TNF-alpha, PDK1 could phosphorylate RSK2 and activated RSK2, then promoting the activation of NF-kappaB.
In cancer cells resistant to PI3Kalpha (show PIK3CA Antibodies) inhibition, PDK1 (show PDK1 Antibodies) blockade restores sensitivity to these therapies. SGK1 (show SGK1 Antibodies), which is activated by PDK1 (show PDK1 Antibodies), contributes to the maintenance of residual mTORC1 activity through direct phosphorylation and inhibition of TSC2 (show TSC2 Antibodies).
Results suggest that Ser (show SIGLEC1 Antibodies)-64 is an important phosphorylation site that is part of a positive feedback loop for human PDK1 (show PDK1 Antibodies)-PKCtheta (show PRKCQ Antibodies);-mediated T cell activation.
our results offer significant insight into how PIK3CA (show PIK3CA Antibodies) overexpression drives squamous cell carcinoma (HNSCC) invasion and metastasis, providing a rationale for targeting PI3K/PDK1 and TGFb (show TGFB1 Antibodies) signaling in advanced HNSCC patients with PIK3CA (show PIK3CA Antibodies) amplification
PDK1 signaling regulates the basal-to-suprabasal switch in developing epidermis by acting as both an activator and organizer of asymmetric cell division and the Notch (show NOTCH1 Antibodies)-dependent differentiation program.
Data indicate that mammary-specific ablation of 3-phosphoinositide dependent protein kinase 1 (PDK1) could delay tumor initiation, progression and metastasis in a spontaneous mouse tumor model.
PDK1 was highly expressed in synovia of collagen-induced-arthritis mice compared to control. The expressions of PDK1, p-PDK1, RSK2 (show RPS6KA3 Antibodies) and p-RSK2 (show RPS6KA3 Antibodies) were all up-regulated in CIA (show NCOA5 Antibodies) compared with normal. This indicated that PDK1/RSK2 (show RPS6KA3 Antibodies) may participate in inflammatory progress of RA.
PDK1 is required for Ca(2 (show CA2 Antibodies)+)-dependent platelet activation on stimulation of collagen receptor (show ITGA2 Antibodies) glycoprotein VI, arterial thrombotic occlusion, and ischemic stroke in vivo.
In conclusion, we have identified that ARL15 acts as an insulin (show INS Antibodies)-sensitizing effector molecule to upregulate the phosphorylation of members of the canonical IR/IRS1 (show IRS1 Antibodies)/PDPK1/AKT (show AKT1 Antibodies) insulin (show INS Antibodies) pathway by interacting with its GAP ASAP2 (show ASAP2 Antibodies) and activating PDPK1. This research may provide new insights into GTPase (show RACGAP1 Antibodies)-mediated insulin (show INS Antibodies) signalling regulation and facilitate the development of new pharmacotherapeutic targets for insulin (show INS Antibodies) sensitizati
Only when suboptimal doses of Akt (show AKT1 Antibodies)-Pdpk1 interaction inhibitor NSC156529 were used an additive effect with Notch (show NOTCH1 Antibodies) inhibition was seen. We conclude that the Akt (show AKT1 Antibodies) pathway inhibitor NSC156529 is potentially useful as single treatment for liver tumors with hyperactivated Akt (show AKT1 Antibodies) signaling.
Xanthium strumarium methanolic extract exerts anti-inflammatory activity in vitro and in vivo by inhibiting PDK1 kinase activity and blocking signaling to its downstream transcription factor, NF-kappaB (show NFKB1 Antibodies).
PDPK1 is required for exercise-induced cardiac hypertrophy but does not contribute to exercise-induced increases in mitochondrial function.
The PDK1 knock-in mice displayed a reduced brain size due to a reduction in neuronal cell size rather than cell number.
The authors show that loss of frataxin homolog (fh (show FXN Antibodies)) in Drosophila leads to iron toxicity, which in turn induces sphingolipid synthesis and ectopically activates 3-phosphoinositide dependent protein kinase-1 (Pdk1) and myocyte enhancer factor-2 (Mef2 (show MYEF2 Antibodies)).
PDK1 is also a presynaptic protein, though it is distributed more broadly.
dS6K activity is dependent on the Drosophila homologue of the phosphoinositide-dependent protein kinase (show CDK7 Antibodies) 1, dPDK1
at least three C. elegans MTMs play essential roles in coelomocyte endocytosis, a process that also requires VPS34 (show PIK3C3 Antibodies) (PI3K)
Piriformospora indica-stimulated growth response is mediated by a pathway consisting of the PLD-PDK1-OXI1 cascade.
PDK1 (show PDK1 Antibodies) undergoes autophosphorylation at several sites; mutation of Ser (show SIGLEC1 Antibodies)-276 to Ala resulted in enzyme with no detectable autophosphorylation; other sites important for autophosphorylation &/or activity were Asp (show ASIP Antibodies)-167, Thr (show TRH Antibodies)-176, & Thr (show TRH Antibodies)-211
PDK1 (show PDK1 Antibodies) is a potent enhancer of PID (show MTA2 Antibodies) activity.
specific lipid signaling pathways converge on PTI1-2 via the PDK1-OXI1 axis
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and single representatives of the gamma, delta, and epsilon subunits. The proton channel likely has nine subunits (a, b, c, d, e, f, g, F6 and 8). There are three separate genes which encode subunit c of the proton channel and they specify precursors with different import sequences but identical mature proteins. The protein encoded by this gene is one of three precursors of subunit c. Alternatively spliced transcript variants encoding different isoforms have been identified. This gene has multiple pseudogenes.
3-phosphoinositide-dependent protein kinase 1
, 3-phosphoinositide dependent protein kinase-1
, pkB kinase
, protein kinase B kinase
, PkB kinase like gene 1
, Pkb kinase
, ATP synthase c subunit
, ATP synthase lipid-binding protein, mitochondrial
, ATP synthase proteolipid P2
, ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9)
, ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9)
, ATPase protein 9
, ATPase subunit C
, mitochondrial ATP synthase, subunit C (subunit 9)
, phosphoinositide dependent kinase 1
, phosphoinositide-dependent kinase 1
, protein kinase 61C
, serine/threonine protein kinase
, pyruvate dehydrogenase kinase 1
, pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 1, mitochondrial